Stock market today: Stocks fall as investors rotate out of tech into Jackson Hole
ALAMEDA, Calif. - Penumbra, Inc. (NYSE:PEN) saw its shares rise 3.2% after the thrombectomy device maker reported fourth quarter earnings and revenue that exceeded analyst expectations.
The company posted adjusted earnings per share of $0.97, surpassing the consensus estimate of $0.90. Revenue for the quarter came in at $321.3 million, above the $311.32 million analysts had projected.
Penumbra’s adjusted revenue grew 12.9% YoY to $321.3 million in Q4, excluding a $5.8 million impact from an Italian government payback provision. The company’s thrombectomy products were a key driver, with sales rising 16.8% to $222.7 million.
For the full year 2025, Penumbra projects revenue between $1.34 billion and $1.36 billion, representing 12-14% growth over 2024. This outlook is slightly below the $1.362 billion consensus estimate.
The company expects its U.S. thrombectomy franchise to grow 19-20% in 2025, fueled by its computer-assisted vacuum thrombectomy products. Penumbra also anticipates expanding its gross margin by at least 100 basis points to over 67% for the full year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.